HLS Therapeutics appoints Linda Maxwell, Mark DeLong as independent directors
Bitget2026/10/01 11:02- HLS Therapeutics appointed Linda Maxwell, M.D. and Mark DeLong as independent directors, replacing Kyle Dempsey and Christine Elliott.
- Board size remains eight directors, including six independent directors.
- Maxwell, a director at ImmunityBio and United Therapeutics, joins the Audit Committee.
- DeLong, CEO of Arrakis Therapeutics and former Apellis chief business and strategy officer, joins the Compensation and Governance Committee.
- Elliott stepped down from the board, returning as a consultant focused on healthcare policy and government relations.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Traders are betting on rising US Treasury yields, short positions surge and push up repo costs
Short positions on government bonds continue to increase, driving up the cost of repo borrowing.
Mattel, the maker of Barbie dolls, surges 19%! Acquired by Authentic Brands Group with an offer possibly exceeding $20 per share
According to media reports, Authentic Brands Group has privately approached Mattel to discuss an acquisition offer. The bid could exceed $20 per share, corresponding to an overall valuation of around $6 billion or higher. There is no guarantee that both parties will eventually reach an agreement. Additionally, with a new CEO about to take charge at Mattel, whose strategic plans have yet to be clarified, the potential deal may become even more complex.
The British Pound slides again as UK government bonds sell off
Horace Mann Completes Acquisition of Employee Services
Crypto prices
More
